Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6Prostatic Neoplasms 4Colorectal Neoplasms 4Colonic Neoplasms 4Radiodermatitis 2Pancreatic Neoplasms 2Pain 2Neoplasms 2Multiple Myeloma 2Breast Carcinoma In Situ 2Adenomatous Polyposis Coli 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Stomatitis 1Smoldering Multiple Myeloma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Neoplasm Metastasis 1Monoclonal Gammopathy of Undetermined Significance 1Leukemia, Lymphocytic, Chronic, B-Cell 1Head and Neck Neoplasms 1Fatigue 1Endometrial Neoplasms 1Condylomata Acuminata 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma 1Adenocarcinoma 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 11Vaccines, Synthetic 7Papillomavirus Vaccines 6Vaccines 3Imiquimod 3Gels 3green tea extract polyphenone E 2Trichloroacetic Acid 2Duration of Therapy 2Cantharidin 2ranpirnase 1polyphenon E 1nanocurcumin 1human papillomavirus vaccine, L1 type 16, 18 1berdazimer sodium 1Viusid 1VP-102 1Therapies, Investigational 1Tea 1Surgical Procedures, Operative 1Omiganan 1Ointments 1Medical Records 1Interleukin-4 1Human Papillomavirus Recombinant Vaccine nonavalent 1Hepatitis B Vaccines 1GS-9191 1Ethanol 1Cyclophosphamide 1Curcumin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Condylomata Acuminata × Curcumin × Clear all
NCT06281353 2024-02-28

The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions Tissue

Indonesia University

Phase 2/3 Completed
78 enrolled

Condylomata Acuminata

Data powered by HemOnc (CC BY 4.0) Colophon âš¡